EULAR Corporate members
EULAR is set up of four types of institutional members: scientific societies, national organisations of people with arthritis/rheumatism and health professionals as well as corporate members.
AbbVie
AMGEN
AstraZeneca
Biogen International GmbH
Boehringer Ingelheim Pharma GmbH & Co. KG
Bristol-Myers Squibb UPSA
Celltrion Healthcare Co. Ltd.
FRESENIUS KABI SWISSBIOSIM
Galapagos
Gilead Sciences
GlaxoSmithKline
Grünenthal GmbH
Hoffmann-La Roche Ltd.
IBSA Institut Biochimique SA
Janssen
Lilly
medac GmbH
MENARINI FARMACEUTICA INTERNAZIONALE
Novartis Pharma AG
Pfizer Pharmaceutical Group
Samsung Bioepis
Sanofi Genzyme
TRB Chemedica International SA
UCB PHARMA SA
Vifor Fresenius Medical Care Renal Pharma Ltd.
Related Information
The EULAR Family
A presentation of the EULAR member organisations.
EULAR Governance
EULAR is governed by an elected board composed by 4 experts in rheumatology and one representative of each pillar (organisations representing other health professionals in rheumatology, patient organisations and scientific societies). Our activities are overseen by 5 content committees and 4 representation committees whose activities are delivered by several hundred expert rheumatology volunteers.
EULAR Communities
EULAR underscores the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs.
EULAR comprises the HPR, PARE and EMEUNET communities, which include 105 member societies / organisations, working on a variety of activities supporting EULAR objectives.
